US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Arin Tactical Tail Risk ETF

93.56

-0.5096-0.54%

Post-market: 93.560.00000.00%16:10 EDT

Volume:4K

Turnover:370.95K

Market Cap:94.42M

PE:- -

High:93.65

Open:93.65

Low:93.56

Close:94.07

52wk High:94.45

52wk Low:45.10

Shares:1.01M

Float Shares:1.01M

Volume Ratio:2.96

T/O Rate:0.39%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

DKSH Partners with BridgeBio to Distribute ATTR-CM Drug in Key Asia-Pacific Markets

AstraZeneca Advances Dual ATTR-CM Therapy With New Phase IIb Trial

Acoramidis Continues to Demonstrate Disease-Modifying Effects in ATTR-CM, Reducing sTTR Variability and Outpatient Worsening Heart Failure

BEYONTTRA™ (acoramidis), the First Near-Complete TTR Stabilizer (≥90%), Approved by ANVISA to Treat ATTR-CM in Brazil

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ATTR"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ATTR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ATTR\",,,,,undefined,":{"symbol":"ATTR","market":"US","secType":"STK","nameCN":"Arin Tactical Tail Risk ETF","latestPrice":93.5615,"timestamp":1782244800000,"preClose":94.0711,"halted":0,"volume":3961,"hourTrading":{"tag":"盘后","latestPrice":93.5615,"preClose":93.5615,"latestTime":"16:10 EDT","volume":2,"amount":187.123,"timestamp":1782245404789,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.005417179133655353,"floatShares":1009146,"shares":1009146,"eps":0,"marketStatus":"Post-Mkt","change":-0.5096,"latestTime":"06-23 19:45:31 EDT","open":93.65,"high":93.65,"low":93.5615,"amount":370948,"amplitude":0.000941,"askPrice":140.44,"askSize":200,"bidPrice":46.82,"bidSize":200,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1782259200000},"marketStatusCode":4,"adr":0,"exchange":"CBOE","adjPreClose":94.0711,"sharesOutstanding":989146,"nav":93.98,"aum":94839541.08,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":93.5615,"preClose":93.5615,"latestTime":"16:10 EDT","volume":2,"amount":187.123,"timestamp":1782245404789,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":2.959504},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ATTR\",,,,,undefined,":{"symbol":"ATTR","floatShares":1009146,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":2.959504,"shares":1009146,"dividePrice":0,"high":93.65,"amplitude":0.000941,"preClose":94.0711,"low":93.5615,"week52Low":45.1,"pbRate":"--","week52High":94.454,"institutionHeld":0,"latestPrice":93.5615,"eps":0,"divideRate":0,"volume":3961,"delay":0,"ttmEps":0,"open":93.65,"prevYearClose":90.4492,"prevWeekClose":94.0711,"prevMonthClose":94.454,"prevQuarterClose":90.875,"fiveDayClose":94.1485,"twentyDayClose":94.0724,"sixtyDayClose":90.5},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ATTR\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ATTR\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ATTR\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ATTR\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2642406644","title":"DKSH Partners with BridgeBio to Distribute ATTR-CM Drug in Key Asia-Pacific Markets","url":"https://stock-news.laohu8.com/highlight/detail?id=2642406644","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642406644?lang=en_us&edition=fundamental","pubTime":"2026-06-11 13:33","pubTimestamp":1781156020,"startTime":"0","endTime":"0","summary":"An update from DKSH Holding AG ( ($CH:DKSH) ) is now available. DKSH’s Healthcare unit has entered a strategic distribution partnership with U.S. b...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/dksh-partners-with-bridgebio-to-distribute-attr-cm-drug-in-key-asia-pacific-markets?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/dksh-partners-with-bridgebio-to-distribute-attr-cm-drug-in-key-asia-pacific-markets?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","BK4588","BK4585","ATTR","XLV","XBI","CM","LABU","BK4207"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642420113","title":"AstraZeneca Advances Dual ATTR-CM Therapy With New Phase IIb Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2642420113","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642420113?lang=en_us&edition=fundamental","pubTime":"2026-06-11 00:33","pubTimestamp":1781109232,"startTime":"0","endTime":"0","summary":"AstraZeneca plc ($GB:AZN) announced an update on their ongoing clinical study. AstraZeneca has launched a new mid‑stage study in heart disease tied...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/astrazeneca-advances-dual-attr-cm-therapy-with-new-phase-iib-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/astrazeneca-advances-dual-attr-cm-therapy-with-new-phase-iib-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CM","ATTR","BK4207"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634821492","title":"Acoramidis Continues to Demonstrate Disease-Modifying Effects in ATTR-CM, Reducing sTTR Variability and Outpatient Worsening Heart Failure","url":"https://stock-news.laohu8.com/highlight/detail?id=2634821492","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634821492?lang=en_us&edition=fundamental","pubTime":"2026-05-11 21:30","pubTimestamp":1778506200,"startTime":"0","endTime":"0","summary":"-Acoramidis increased sTTR early and significantly reduced intra-individual sTTR variability versus placebo (p<0.001), which is associated with reduced ACM, further reinforcing its differentiated prof","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/11/3291995/0/en/Acoramidis-Continues-to-Demonstrate-Disease-Modifying-Effects-in-ATTR-CM-Reducing-sTTR-Variability-and-Outpatient-Worsening-Heart-Failure.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4207","LU2308191902.HKD","ATTR","LU0187121727.USD","ACM","CM","LU1861214812.USD","LU1939255532.USD","LU2360107325.USD","LU2244417387.USD","LU1861219969.SGD","BK4129","LU0124676726.USD","EMA","BK4516","LU2298064838.USD","BK4081","LU0689626769.HKD","LU2238339852.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633180927","title":"BEYONTTRA™ (acoramidis), the First Near-Complete TTR Stabilizer (≥90%), Approved by ANVISA to Treat ATTR-CM in Brazil","url":"https://stock-news.laohu8.com/highlight/detail?id=2633180927","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633180927?lang=en_us&edition=fundamental","pubTime":"2026-05-06 19:30","pubTimestamp":1778067000,"startTime":"0","endTime":"0","summary":"- The approval of Beyonttra in Brazil is based on positive results from the Phase 3 ATTRibute-CM study, in which acoramidis demonstrated the most rapid benefit seen in any Phase 3 study of ATTR-CM to ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/06/3288693/0/en/BEYONTTRA-acoramidis-the-First-Near-Complete-TTR-Stabilizer-90-Approved-by-ANVISA-to-Treat-ATTR-CM-in-Brazil.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4207","EWZS","CM","ATTR"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":4,"pageCount":1,"totalSize":16,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/ATTR\",params:#limit:6,delay:false,,,undefined,":[]}}